Table 7.
Fracture Reduction in the Estrogen Plus Progestin Women's Health Initiative[9]
| Estrogen Plus Progestin (HT) (N = 8506) | Placebo (N = 8102) | ||||||
|---|---|---|---|---|---|---|---|
| Fractures | Reduced per 10,000 per year |
Number HT |
Per 10,000/yr HT |
Number placebo |
Per 10,000/yr Placebo |
Percent (%) reduction |
Hazard ratio/95% nCI |
| Total | 47 | 733 | 152 | 896 | 199 | 24 | 0.76/0.69-0.83 |
| Hip | 5 | 52 | 11 | 73 | 16 | 34 | 0.67/0.47-0.96 |
| Lower arm and wrist | 18 | 189 | 44 | 245 | 62 | 32 | 0.71/0.59-0.85 |
| Clinical vertebral | 6 | 40 | 11 | 61 | 17 | 34 | 0.65/0.46-0.92 |